Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


11.02.2019

1 Arch Virol
1 Blood
3 Clin Infect Dis
1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
5 Gastroenterology
3 Hepatology
1 Int J STD AIDS
1 J Clin Microbiol
1 J Infect Dis
1 J Med Virol
1 J Pediatr
1 J Viral Hepat
2 J Virol
2 Lancet
1 Lancet Infect Dis
3 PLoS One
2 PLoS Pathog
3 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. DENG H, Liang S, Liu H, Xu M, et al
    Genetic characterization of a novel unique recombinant form of HIV-1 originating from subtype A1 and C in Guangdong Province, China.
    Arch Virol. 2019;164:285-290.
    PubMed     Text format     Abstract available


    Blood


  2. Ren W, Ye X, Su H, et al. Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma. Blood. 2018;131(24):2670-2681.
    Blood. 2019;133:620.
    PubMed     Text format    


    Clin Infect Dis

  3. BROWN TT
    Hypogonadism in Men With Hepatitis C: What Is a Clinician to Do?
    Clin Infect Dis. 2019 Feb 2. pii: 5305923. doi: 10.1093.
    PubMed     Text format    

  4. BROUWER WP, Chan HL, Lampertico P, Hou J, et al
    Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.
    Clin Infect Dis. 2019 Feb 2. pii: 5305981. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. CHAUDHURY CS, Mee T, Chairez C, McLaughlin M, et al
    Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance.
    Clin Infect Dis. 2019 Feb 2. pii: 5305922. doi: 10.1093.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  6. KWON JH, Song MJ, Jang JW, Bae SH, et al
    Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naive Patients with Chronic Hepatitis B in Korea.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05489.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  7. DARWEESH SK, Gad AA, Akroof K, ElLatif ZA, et al
    Entecavir and other nucleos(t)ide analogs prophylaxis in hepatitis B virus-related liver transplantation: long-term efficacy and safety.
    Eur J Gastroenterol Hepatol. 2019 Feb 4. doi: 10.1097/MEG.0000000000001377.
    PubMed     Text format     Abstract available


    Gastroenterology

  8. MCNAUGHTON AL, D'Arienzo V, Ansari MA, Lumley SF, et al
    Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood.
    Gastroenterology. 2019;156:384-399.
    PubMed     Text format     Abstract available

  9. XIA Y, Liang TJ
    Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of Hepatitis B Virus Infection.
    Gastroenterology. 2019;156:311-324.
    PubMed     Text format     Abstract available

  10. GEHRING AJ, Protzer U
    Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection.
    Gastroenterology. 2019;156:325-337.
    PubMed     Text format     Abstract available

  11. KULIK L, El-Serag HB
    Epidemiology and Management of Hepatocellular Carcinoma.
    Gastroenterology. 2018 Oct 24. pii: S0016-5085(18)35165.
    PubMed     Text format     Abstract available

  12. COFFIN CS, Zhou K, Terrault NA
    New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection.
    Gastroenterology. 2019;156:355-368.
    PubMed     Text format     Abstract available


    Hepatology

  13. KAMAR N, Pan Q
    No clear evidence for an effect of sofosbuvir against hepatitis E virus in organ-transplant-patients.
    Hepatology. 2019 Feb 5. doi: 10.1002/hep.30546.
    PubMed     Text format     Abstract available

  14. COTTER TG, Paul S, Sandikci B, Couri T, et al
    Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of HCV-Viremic Donors into HCV-Negative Recipients.
    Hepatology. 2019 Jan 31. doi: 10.1002/hep.30540.
    PubMed     Text format     Abstract available

  15. SERPER M
    Direct acting antivirals for patients without advanced liver disease: All for treatment and treatment for all?
    Hepatology. 2018;68:804-806.
    PubMed     Text format    


    Int J STD AIDS

  16. YANCHEVA N, Tzonev R
    A case of late presentation of darunavir-related cholestatic hepatitis.
    Int J STD AIDS. 2019 Feb 5:956462419826723. doi: 10.1177/0956462419826723.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  17. HAN B, Parhy B, Zhou E, Hsieh D, et al
    In vitro Susceptibility of HCV Genotype 1 through 6 Clinical Isolates to the Pan-genotypic NS3/4A Inhibitor Voxilaprevir.
    J Clin Microbiol. 2019 Feb 6. pii: JCM.01844-18. doi: 10.1128/JCM.01844.
    PubMed     Text format     Abstract available


    J Infect Dis

  18. LEUNG J, Peacock A, Colledge S, Grebely J, et al
    A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs - do gender differences vary by country-level indicators?
    J Infect Dis. 2019 Feb 6. pii: 5307802. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  19. GHASEMI A, Zadsar M, Shaiegan M, Samiei S, et al
    Human platelet antigens polymorphisms; Association to the development of liver fibrosis in patients with chronic hepatitis C.
    J Med Virol. 2019 Feb 6. doi: 10.1002/jmv.25423.
    PubMed     Text format     Abstract available


    J Pediatr

  20. WEHRMAN A, Waisbourd-Zinman O, Shah A, Hilmara D, et al
    Steroid Free Treatment of Autoimmune Hepatitis in Selected Children.
    J Pediatr. 2019 Feb 2. pii: S0022-3476(19)30022.
    PubMed     Text format     Abstract available


    J Viral Hepat

  21. CHEN WC, Wei CK, Lee JC
    MicroRNA-let-7c suppresses hepatitis C virus replication by targeting Bach1 for induction of heme oxygenase-1 expression.
    J Viral Hepat. 2019 Jan 31. doi: 10.1111/jvh.13072.
    PubMed     Text format     Abstract available


    J Virol

  22. BANG BR, Li M, Tsai KN, Aoyagi H, et al
    Regulation of HCV infection by Cellular Retinoic Acid Binding Proteins through the modulation of lipid droplet abundance.
    J Virol. 2019 Feb 6. pii: JVI.02302-18. doi: 10.1128/JVI.02302.
    PubMed     Text format     Abstract available

  23. HARICHANDRAN K, Shen Y, Tsoris SS, Lee SC, et al
    Hepatitis Delta Antigen Regulates mRNA and Antigenome RNA Levels during Hepatitis Delta Virus Replication.
    J Virol. 2019 Feb 6. pii: JVI.01989-18. doi: 10.1128/JVI.01989.
    PubMed     Text format     Abstract available


    Lancet

  24. HEFFERNAN A, Cooke GS, Nayagam S, Thursz M, et al
    Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model.
    Lancet. 2019 Jan 28. pii: S0140-6736(18)32277.
    PubMed     Text format     Abstract available

  25. WIKTOR S
    How feasible is the global elimination of HCV infection?
    Lancet. 2019 Jan 28. pii: S0140-6736(18)32750.
    PubMed     Text format    


    Lancet Infect Dis

  26. WALKER S, Stoove M, Wilson M, Higgs P, et al
    Understanding HIV and hepatitis C virus risk among incarcerated young men with histories of injecting drug use.
    Lancet Infect Dis. 2019;19:130-131.
    PubMed     Text format    


    PLoS One

  27. SHTEYER E, Shekhtman L, Zinger T, Harari S, et al
    Correction: Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography.
    PLoS One. 2019;14:e0212252.
    PubMed     Text format     Abstract available

  28. SHENGE JA, Odaibo GN, Olaleye DO
    Phylogenetic analysis of hepatitis C virus among HIV/ HCV co-infected patients in Nigeria.
    PLoS One. 2019;14:e0210724.
    PubMed     Text format     Abstract available

  29. ANABIRE NG, Aryee PA, Abdul-Karim A, Abdulai IB, et al
    Prevalence of malaria and hepatitis B among pregnant women in Northern Ghana: Comparing RDTs with PCR.
    PLoS One. 2019;14:e0210365.
    PubMed     Text format     Abstract available


    PLoS Pathog

  30. RODER AE, Vazquez C, Horner SM
    The acidic domain of the hepatitis C virus NS4A protein is required for viral assembly and envelopment through interactions with the viral E1 glycoprotein.
    PLoS Pathog. 2019;15:e1007163.
    PubMed     Text format     Abstract available

  31. BAMFORD CGG, Aranday-Cortes E, Filipe IC, Sukumar S, et al
    A polymorphic residue that attenuates the antiviral potential of interferon lambda 4 in hominid lineages.
    PLoS Pathog. 2018;14:e1007307.
    PubMed     Text format     Abstract available


    Vaccine

  32. STASI C, Monnini M, Cellesi V, Salvadori M, et al
    Screening for hepatitis B virus and accelerated vaccination schedule in prison: A pilot multicenter study.
    Vaccine. 2019 Feb 4. pii: S0264-410X(19)30125.
    PubMed     Text format     Abstract available

  33. BORRAS E, Urbiztondo L, Carmona G, Jane M, et al
    Effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia 21 years after its introduction.
    Vaccine. 2019 Jan 29. pii: S0264-410X(19)30078.
    PubMed     Text format     Abstract available

  34. KASPER AK, Pallotta AM, Kovacs CS, Spinner ML, et al
    Infectious diseases consult improves vaccination adherence in kidney transplant candidates.
    Vaccine. 2018 Jul 23. pii: S0264-410X(18)30899.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: